Literature DB >> 21951536

Zebrafish as a model for the study of human cancer.

Julia Etchin1, John P Kanki, A Thomas Look.   

Abstract

Zebrafish provide an exciting animal model system for the study of human cancers. During the last few years many zebrafish models of cancer have been generated that recapitulate human hematologic malignancies and solid tumors. Concurrent technological advances have significantly improved the genetic tractability and unique advantage of in vivo imaging in zebrafish, providing a means to dissect the molecular pathways underlying tumor initiation, progression and metastasis. Comparisons of cancer-associated gene expression profiles have demonstrated a high degree of similarity in the gene signatures of specific types of tumor cells in fish and humans, indicating that the contributing genetic pathways leading to cancer are evolutionarily conserved. Furthermore, the high fecundity, optical clarity and small embryo size of zebrafish continue to make it particularly amenable to performing whole-organism small molecule screens to identify targets for therapeutic development. This chapter reviews a wide array of these zebrafish cancer models and illustrates the advantages of the zebrafish system for exploring the molecular mechanisms governing cancer-related cellular processes.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21951536     DOI: 10.1016/B978-0-12-381320-6.00013-8

Source DB:  PubMed          Journal:  Methods Cell Biol        ISSN: 0091-679X            Impact factor:   1.441


  24 in total

1.  Scaling up to study brca2: the zeppelin zebrafish mutant reveals a role for brca2 in embryonic development of kidney mesoderm.

Authors:  Bridgette E Drummond; Rebecca A Wingert
Journal:  Cancer Cell Microenviron       Date:  2018-04-09

2.  Conservation and early expression of zebrafish tyrosine kinases support the utility of zebrafish as a model for tyrosine kinase biology.

Authors:  Anil Kumar Challa; Kiranam Chatti
Journal:  Zebrafish       Date:  2012-12-12       Impact factor: 1.985

3.  Zebrafish keratocyte explants to study collective cell migration and reepithelialization in cutaneous wound healing.

Authors:  Jose L Rapanan; Agnes S Pascual; Chandana K Uppalapati; Kimbal E Cooper; Kathryn J Leyva; Elizabeth E Hull
Journal:  J Vis Exp       Date:  2015-02-25       Impact factor: 1.355

4.  In Vivo Targeting of Xenografted Human Cancer Cells with Functionalized Fluorescent Silica Nanoparticles in Zebrafish.

Authors:  Xiaodan Qin; Fabrice F J Laroche; Saquib Ahmed M A Peerzade; Andrew Lam; Igor Sokolov; Hui Feng
Journal:  J Vis Exp       Date:  2020-05-08       Impact factor: 1.355

5.  Human amyloidogenic light chain proteins result in cardiac dysfunction, cell death, and early mortality in zebrafish.

Authors:  Shikha Mishra; Jian Guan; Eva Plovie; David C Seldin; Lawreen H Connors; Giampaolo Merlini; Rodney H Falk; Calum A MacRae; Ronglih Liao
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-04-26       Impact factor: 4.733

6.  An in vivo platform for rapid high-throughput antitubercular drug discovery.

Authors:  Kevin Takaki; Christine L Cosma; Mark A Troll; Lalita Ramakrishnan
Journal:  Cell Rep       Date:  2012-07-20       Impact factor: 9.423

7.  Danio rerio: Small Fish Making a Big Splash in Leukemia.

Authors:  Barbara Squiban; J Kimble Frazer
Journal:  Curr Pathobiol Rep       Date:  2014-06

Review 8.  Targeting ALK in neuroblastoma--preclinical and clinical advancements.

Authors:  Erica L Carpenter; Yael P Mossé
Journal:  Nat Rev Clin Oncol       Date:  2012-05-15       Impact factor: 66.675

Review 9.  Pre-clinical tumor models of primary brain tumors: Challenges and opportunities.

Authors:  Farhana Akter; Brennan Simon; Nadine Leonie de Boer; Navid Redjal; Hiroaki Wakimoto; Khalid Shah
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2020-10-23       Impact factor: 10.680

Review 10.  From fish bowl to bedside: The power of zebrafish to unravel melanoma pathogenesis and discover new therapeutics.

Authors:  Ellen van Rooijen; Maurizio Fazio; Leonard I Zon
Journal:  Pigment Cell Melanoma Res       Date:  2017-06-08       Impact factor: 4.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.